You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 152 No. 2, FEBRUARY 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Amantadine-Resistant Influenza A in a Nursing Facility

John Degelau, MD; Salma K. Somani, PharmD; Susan L. Cooper, MS; David R. P. Guay, PharmD; Kent B. Crossley, MD

Arch Intern Med. 1992;152(2):390-392.


Abstract

Rapid index case treatment and amantadine prophylaxis were implemented in two nursing homes exposed to influenza A. Facility A had no isolation of cases, and 18 of 22 cases occurred after amantadine hydrochloride therapy was initiated. Three patients exhibited amantadine-resistant virus. Facility B had day 1 isolation of the index case. A facility-wide outbreak did not occur. The experience of these facilities suggests that concurrent amantadine treatment and prophylaxis without adequate case isolation may promote further influenza A infection in a nursing facility.

(Arch Intern Med. 1992;152:390-392)



Author Affiliations

From the Section of Geriatric Medicine, Department of Internal Medicine (Drs Degelau and Crossley), and the Section of Clinical Pharmacy (Drs Somani, Guay, and Ms Cooper), St Paul-Ramsey Medical Center, St Paul, Minn.


Footnotes

Accepted for publication August 6, 1991.

Reprint requests to Department of Internal Medicine, 640 Jackson St, St Paul, MN 55101 (Dr Degelau).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Adamantane Resistance Among Influenza A Viruses Isolated Early During the 2005-2006 Influenza Season in the United States
Bright et al.
JAMA 2006;295:891-894.
ABSTRACT | FULL TEXT  

Detection of Amantadine-Resistant Influenza A Virus Strains in Nursing Homes by PCR-Restriction Fragment Length Polymorphism Analysis with Nasopharyngeal Swabs
Saito et al.
J. Clin. Microbiol. 2002;40:84-88.
ABSTRACT | FULL TEXT  

Isolation of Amantadine-Resistant Influenza A Viruses (H3N2) from Patients following Administration of Amantadine in Japan
Iwahashi et al.
J. Clin. Microbiol. 2001;39:1652-1653.
ABSTRACT | FULL TEXT  

Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts: A Randomized Controlled Trial
Welliver et al.
JAMA 2001;285:748-754.
ABSTRACT | FULL TEXT  

Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza: A Randomized Controlled Trial
Treanor et al.
JAMA 2000;283:1016-1024.
ABSTRACT | FULL TEXT  

Duration of Antiviral Prophylaxis During Nursing Home Outbreaks of Influenza A: A Comparison of 2 Protocols
Drinka et al.
Arch Intern Med 1998;158:2155-2159.
ABSTRACT | FULL TEXT  

Amantadine-Resistant Influenza A in Nursing Homes: Identification of a Resistant Virus Prior to Drug Use
Houck et al.
Arch Intern Med 1995;155:533-537.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.